Invesque Inc. (TSE:IVQ – Get Free Report)’s stock price traded down 10.9% during mid-day trading on Tuesday . The company traded as low as C$0.25 and last traded at C$0.25. 25,515 shares traded hands during trading, an increase of 123% from the average session volume of 11,454 shares. The stock had previously closed at C$0.28.
Invesque Stock Down 2.0 %
The stock has a market capitalization of C$13.75 million, a price-to-earnings ratio of -0.11 and a beta of 1.16. The company has a debt-to-equity ratio of 441.67, a quick ratio of 0.35 and a current ratio of 0.15. The business has a 50-day moving average of C$0.36 and a 200-day moving average of C$0.34.
Invesque (TSE:IVQ – Get Free Report) last released its earnings results on Friday, March 15th. The company reported C($0.82) earnings per share for the quarter. The firm had revenue of C$63.03 million during the quarter. Invesque had a negative net margin of 50.79% and a negative return on equity of 47.56%. On average, sell-side analysts expect that Invesque Inc. will post 0.63 EPS for the current year.
Invesque Company Profile
Invesque Inc operates as a health care real estate company in North America. The company's investment property portfolio includes investments in independent living, assisted living, memory care, skilled nursing, and transitional care properties. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services.
Further Reading
- Five stocks we like better than Invesque
- How to Most Effectively Use the MarketBeat Earnings Screener
- Hasbro’s Management Made All the Right Calls This Quarter
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- ESG Stocks, What Investors Should Know
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Invesque Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesque and related companies with MarketBeat.com's FREE daily email newsletter.